Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Emerging Market Stocks Eye Renaissance

BY | ETF Database
03/12/2025 | 138 VIEWS
In the early part of this century, emerging market equities were all the rage. And those stocks delivered on the hype. But following the global financial crisis, a lengthy era of outperformance by domestic equities was ushered in.So clear was the leadership of U.S. stocks and laggard status of emerging markets equivalents that advisors and investors had little motivation to take on the added risk associated with the latter. That script maybe flipping. There’s much more of 2025 to go. But it’s clear the MSCI Emerging Markets Index is in the green to start the year,  while S&P 500 is not. Count the WisdomTree Emerging Markets ex-State-Owned Enterprises Fund (XSOE A) among the ETFs tracking developing-world stocks that’s also beating the S&P 500 to start 2025. As its name implies, XSOE eschews exposure to state-run companies. That group is known for slower rates of growth in the emerging market complex. That avoidance could be a positive if emerging market stocks extend recent bullishness over the duration of 2025.Why XSOE Could ExcelValuation has long been the battle cry of emerging market equity supporters. And in what could be good news for those considering XSOE, the asset class remains attractive on that basis. “For years now, emerging-markets stocks have traded at a deep valuation discount to their US counterparts,” noted Morningstar analyst Dan Lefkovitz. “The trailing 12-month price/earnings ratio on the Morningstar Emerging Markets Index was just 14.0 as of the end of 2024, compared with 26.4 for US stocks. We saw an even bigger gap in 2021 when the US traded at twice the multiple of emerging-markets stocks.” Those inviting multiples are pertinent when evaluating XSOE. That’s because the ETF allocates 21.43% of its roster to India stocks, which have long been viewed as expensive. Additionally, the ETF devotes 31.15% of its weight to tech stocks. But the good news is emerging market growth names, broadly speaking, trade at noticeable discounts to domestic equivalents. Another factor that could work in favor of XSOE is declining correlations between emerging market stocks and U.S. monetary policy. There was a time when those stocks were highly dependent on favorable interest rates in the U.S. But that’s waning, and that could be a good thing. That’s because the Federal Reserve may not have the room to lower rates much, if at all, in 2025.A Weakened Link?“The link between emerging-markets’ performance and US interest rates looks to have weakened. The Morningstar Emerging Markets Index outperformed only marginally in 2020 after global central banks responded to the pandemic with rate cuts,” added Lefkovitz. “And in the bear market of 2022, emerging-markets equities declined in line with their developed counterparts, despite the most aggressive rate hikes in a generation.” For more news, information, and analysis, visit the Modern Alpha Channel. This article was prepared as part of WisdomTree’s general paid sponsorship of VettaFi | ETF Trends. This specific content within and any opinions expressed therein belong solely to VettaFi and do not reflect the opinion or analysis of WisdomTree, its employees, or its affiliates. Content published on VettaFi | ETF Trends is provided for educational purposes only and should not be considered investment or tax advice. For investment or tax advice, please consult a financial professional.  WisdomTree is an independent company, unaffiliated with VettaFi | ETF Trends. WisdomTree has not been involved with the preparation of the content supplied by VettaFi | ETF Trends. It does not guarantee, or assume any responsibility for its content.

More Commentary

Active Value ETF TVAL Adds a Quarter Billion in 1 Month
BY | ETF Database
03/31/2025 | 117 VIEWS
Gold's Rally Continues to Tee Up Opportunities for Miners
BY | ETF Database
03/31/2025 | 80 VIEWS
Active ETF Specialist T. Rowe Price Adds 2 New Active Funds
BY | ETF Database
03/28/2025 | 196 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.